Traxoprodil, a selective antagonist of the NR2B subunit of the NMDA receptor, potentiates the antidepressant-like effects of certain antidepressant drugs in the forced swim test in mice
Open Access
- 29 February 2016
- journal article
- research article
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 31 (4) , 803-814
Abstract
One of the newest substances, whose antidepressant activity was shown is traxoprodil, which is a selective antagonist of the NR2B subunit of the NMDA receptor. The main goal of the present study was to evaluate the effect of traxoprodil on animals’ behavior using the forced swim test (FST), as well as the effect of traxoprodil (10 mg/kg) on the activity of antidepressants, such as imipramine (15 mg/kg), fluoxetine (5 mg/kg), escitalopram (2 mg/kg) and reboxetine (2.5 mg/kg). Serotonergic lesion and experiment using the selective agonists of serotonin receptors 5-HT1A and 5-HT2 was conducted to evaluate the role of the serotonergic system in the antidepressant action of traxoprodil. Brain concentrations of tested agents were determined using HPLC. The results showed that traxoprodil at a dose of 20 and 40 mg/kg exhibited antidepressant activity in the FST and it was not related to changes in animals’ locomotor activity. Co-administration of traxoprodil with imipramine, fluoxetine or escitalopram, each in subtherapeutic doses, significantly affected the animals’ behavior in the FST and, what is important, these changes were not due to the severity of locomotor activity. The observed effect of traxoprodil is only partially associated with serotonergic system and is independent of the effect on the 5-HT1A and 5-HT2 serotonin receptors. The results of an attempt to assess the nature of the interaction between traxoprodil and the tested drugs show that in the case of joint administration of traxoprodil and fluoxetine, imipramine or escitalopram, there were interactions in the pharmacokinetic phase.Keywords
Funding Information
- Funds for Statutory Activity of Medical University of Lublin
This publication has 82 references indexed in Scilit:
- A complex interaction between glycine/NMDA receptors and serotonergic/noradrenergic antidepressants in the forced swim test in miceJournal of Neural Transmission, 2011
- Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trialsBMJ, 2010
- Glutamate Receptor Ion Channels: Structure, Regulation, and FunctionPharmacological Reviews, 2010
- Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive DisorderThe Journal of Clinical Psychiatry, 2010
- Chronic treatment with zinc and antidepressants induces enhancement of presynaptic/extracellular zinc concentration in the rat prefrontal cortexAmino Acids, 2010
- New Therapeutic Targets for Mood DisordersThe Scientific World Journal, 2010
- Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-Resistant DepressionBiological Psychiatry, 2009
- Allosteric modulators of NR2B‐containing NMDA receptors: molecular mechanisms and therapeutic potentialBritish Journal of Pharmacology, 2009
- 5-HT1A receptor function in major depressive disorderProgress in Neurobiology, 2009
- Selective Inhibition of Calcium Entry Induced by Benzylisoquinolines in Rat Smooth MuscleJournal of Pharmacy and Pharmacology, 1992